Reversal of ischemic liver failure by intrasplenic liver cell transplantation.
A model of ischemic hepatic failure in Sprague-Dawley rats (SD) with 100% mortality has been developed by one-hour occlusion of the right portal vein and hepatic artery followed by left 70% hepatectomy. The intrasplenic injection of 40 x 10(6) syngeneic adult or three-day neonatal single liver cell suspensions decreased the mortality from 100% to 50% and 36%, respectively. Mortality decreased with increasing time from the intrasplenic injection of neonatal liver cells to the time of acute hepatic ischemia. Mortality also decreased with increasing interval between hepatic ischemia and removal of the transplanted liver cells by splenectomy. Intrasplenic injection of graded doses of neonatal liver cells decreased mortality from 75% at a dose of 10 x 10(6) cells, to 36% at 160 x 10(6) cells. Treatment of neonatal liver cells with metabolic inhibitors did not significantly affect their ability to reverse acute hepatic ischemia.
Flye
M W
MW
Department of Surgery and Organ Transplantation, Washington University School of Medicine, St Louis, MO.
Lu
X S
XS
Yu
S
S
D000818:Animals; D002469:Cell Separation; D007511:Ischemia / Q000503:physiopathology / Q000628:therapy*; D008099:Liver / Q000098:blood supply* / Q000166:cytology; D008107:Liver Diseases / Q000503:physiopathology / Q000628:therapy*; D016031:Liver Transplantation; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000166:cytology* / Q000503:physiopathology